FIELD: medicine.
SUBSTANCE: group of inventions relates to ophthalmology, and aims at improving visual acuity of a person in need thereof. Composition suitable as an artificial tear comprises sodium carboxymethyl cellulose, glycerol, sodium hyaluronate, Purite, boric acid, sodium borate decahydrate, sodium citrate dihydrate, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, erythrite, sodium hydroxide or hydrochloric acid to bring pH to 7.2 and water for injections or purified water to 100 % of the volume. Alternatively, the composition also contains levocarnitine. Components are used in claimed amounts. To improve the visual acuity of a person in need thereof, said compositions are administered locally in an effective amount.
EFFECT: using the group of inventions makes it possible to improve the composition distribution by the cornea during blinking and to increase its retention on the eye surface.
4 cl, 3 tbl, 11 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRY EYE TREATMENT COMPOSITIONS | 2012 |
|
RU2651046C2 |
| COMPOSITION FOR EFFECTIVE LIPID DELIVERY TO HUMAN TEAR FILM USING SALT-SENSITIVE EMULSION SYSTEM | 2012 |
|
RU2772357C2 |
| OPHTHALMIC COMPOSITIONS WITH IMPROVED DESSICATION PROTECTION AND RETENTION | 2013 |
|
RU2659207C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING SULGLYCOTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT FOR PREVENTING OR TREATING DRY EYES SYNDROME | 2018 |
|
RU2722485C1 |
| HYALURONIC ACID COMPOSITIONS WITH HIGH-ELASTICITY AND METHODS OF USING THEREOF | 2016 |
|
RU2727809C2 |
| OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCULAR SURFACE DAMAGE AND DRY EYE SYMPTOMS | 2019 |
|
RU2806212C2 |
| AUTOCLAVABLE FORM 2 CYCLOSPORIN A PORTION | 2012 |
|
RU2630970C2 |
| OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION AND METHODS OF ITS PREPARATION AND USE | 2019 |
|
RU2812316C2 |
| OPHTHALMIC COMPOSITIONS AND METHODS OF TREATING EYES | 2005 |
|
RU2410081C2 |
| ARTIFICIAL TEARS AND THERAPEUTIC APPLICATION | 2010 |
|
RU2589837C2 |
